| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |